You have stated you are a member of the public.
Zalviso is used to treat acute moderate to severe pain after an operation in adults.
The active substance of Zalviso is sufentanil, which belongs to a group of strong pain-relieving medicines called opioids.
A link to the package leaflet intended for patients can be accessed by the following link:
A link to the summary of product characteristics can be accessed by the following link:
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of this medicine.